Goldman Sachs Group Inc Kezar Life Sciences, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 297,774 shares of KZR stock, worth $1.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
297,774
Previous 1,019,176 70.78%
Holding current value
$1.95 Million
Previous $611,000 62.52%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.53 - $0.77 $382,343 - $555,479
-721,402 Reduced 70.78%
297,774 $229,000
Q2 2024

Aug 13, 2024
BUY
$0.6 - $0.92 $368,682 - $565,312
614,470 Added 151.83%
1,019,176 $611,000
Q1 2024

May 15, 2024
SELL
$0.8 - $1.05 $30,412 - $39,915
-38,015 Reduced 8.59%
404,706 $364,000
Q4 2023

Feb 13, 2024
SELL
$0.72 - $1.15 $678,445 - $1.08 Million
-942,285 Reduced 68.03%
442,721 $420,000
Q3 2023

May 14, 2024
BUY
$1.08 - $2.54 $1.02 Million - $2.39 Million
942,285 Added 212.84%
1,385,006 $1.65 Million
Q3 2023

Nov 14, 2023
BUY
$1.08 - $2.54 $43,244 - $101,704
40,041 Added 2.98%
1,385,006 $1.65 Million
Q2 2023

May 14, 2024
BUY
$2.31 - $3.06 $607,227 - $804,379
262,869 Added 24.29%
1,344,965 $3.3 Million
Q2 2023

Aug 14, 2023
BUY
$2.31 - $3.06 $607,227 - $804,379
262,869 Added 24.29%
1,344,965 $3.3 Million
Q1 2023

May 14, 2024
BUY
$3.13 - $7.31 $1.97 Million - $4.6 Million
628,838 Added 138.74%
1,082,096 $3.39 Million
Q1 2023

May 11, 2023
BUY
$3.13 - $7.31 $1.97 Million - $4.6 Million
628,838 Added 138.74%
1,082,096 $3.39 Million
Q4 2022

May 14, 2024
SELL
$6.39 - $8.8 $3.2 Million - $4.4 Million
-500,334 Reduced 52.47%
453,258 $3.19 Million
Q4 2022

Feb 13, 2023
SELL
$6.39 - $8.8 $3.2 Million - $4.4 Million
-500,334 Reduced 52.47%
453,258 $3.19 Million
Q3 2022

May 14, 2024
BUY
$7.99 - $10.75 $2.17 Million - $2.91 Million
271,020 Added 39.71%
953,592 $8.21 Million
Q3 2022

Nov 10, 2022
BUY
$7.99 - $10.75 $2.17 Million - $2.91 Million
271,020 Added 39.71%
953,592 $8.21 Million
Q2 2022

May 14, 2024
BUY
$4.58 - $17.13 $1.1 Million - $4.11 Million
239,851 Added 54.18%
682,572 $5.65 Million
Q2 2022

Aug 15, 2022
BUY
$4.58 - $17.13 $1.94 Million - $7.25 Million
423,377 Added 163.34%
682,572 $5.65 Million
Q1 2022

May 16, 2022
BUY
$12.3 - $18.33 $2.13 Million - $3.17 Million
172,993 Added 200.68%
259,195 $4.31 Million
Q4 2021

Feb 14, 2022
SELL
$7.44 - $16.72 $1.4 Million - $3.14 Million
-187,539 Reduced 68.51%
86,202 $1.44 Million
Q3 2021

Nov 10, 2021
BUY
$4.85 - $9.73 $1.33 Million - $2.66 Million
273,741 New
273,741 $2.37 Million

Others Institutions Holding KZR

# of Institutions
61
Shares Held
38.4M
Call Options Held
13.8K
Put Options Held
600
View Full List

About Kezar Life Sciences, Inc.

KZR Quotes by TradingView
  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $449M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email